Lifecore Biomedical
LFCR
LFCR
91 hedge funds and large institutions have $323M invested in Lifecore Biomedical in 2019 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 30 increasing their positions, 28 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
7% more repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 28
2.94% less ownership
Funds ownership: 93.14% → 90.21% (-2.9%)
Holders
91
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$4.28M | |
| 2 | +$3.33M | |
| 3 | +$2.63M | |
| 4 |
AC
AltraVue Capital
Bellevue,
Washington
|
+$1.68M |
| 5 |
LCM
Legato Capital Management
San Francisco,
California
|
+$1.07M |
Top Sellers
| 1 | -$6.34M | |
| 2 | -$2.6M | |
| 3 | -$1.89M | |
| 4 |
Morgan Stanley
New York
|
-$1.11M |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$986K |